Sphera Funds Management as of Dec. 31, 2014
Portfolio Holdings for Sphera Funds Management
Sphera Funds Management holds 125 positions in its portfolio as reported in the December 2014 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Novartis (NVS) | 6.9 | $41M | 440k | 92.94 | |
Actavis | 4.7 | $28M | 107k | 257.41 | |
Pfizer (PFE) | 4.6 | $27M | 874k | 31.15 | |
Teva Pharmaceutical Industries (TEVA) | 3.9 | $23M | 396k | 57.51 | |
Salix Pharmaceuticals | 3.1 | $18M | 159k | 114.94 | |
Gilead Sciences (GILD) | 3.0 | $18M | 190k | 94.26 | |
Shire | 2.7 | $16M | 225k | 70.68 | |
Valeant Pharmaceuticals Int | 2.4 | $14M | 99k | 143.11 | |
Biogen Idec (BIIB) | 2.3 | $14M | 40k | 339.45 | |
Isram | 1.9 | $11M | 65M | 0.17 | |
United Therapeutics Corporation (UTHR) | 1.6 | $9.6M | 74k | 129.50 | |
Merck & Co | 1.6 | $9.5M | 168k | 56.79 | |
Mallinckrodt Pub | 1.5 | $9.0M | 91k | 99.03 | |
Bristol Myers Squibb (BMY) | 1.5 | $8.9M | 150k | 59.03 | |
Elbit Systems (ESLT) | 1.5 | $8.9M | 145k | 61.16 | |
Verint Systems (VRNT) | 1.4 | $8.5M | 146k | 58.28 | |
Allergan Inc call | 1.4 | $8.2M | 250k | 32.95 | |
BioMarin Pharmaceutical (BMRN) | 1.2 | $7.2M | 80k | 90.40 | |
Bellicum Pharmaceuticals | 1.2 | $7.0M | 332k | 20.98 | |
iShares Russell 2000 Index (IWM) | 1.1 | $6.5M | 54k | 119.61 | |
Kite Pharma | 1.1 | $6.4M | 111k | 57.67 | |
Sanofi Aventis Wi Conval Rt | 1.1 | $6.2M | 68k | 91.55 | |
Astrazeneca | 1.0 | $6.1M | 87k | 70.39 | |
Eli Lilly & Co. (LLY) | 1.0 | $6.0M | 87k | 68.99 | |
Pharmacyclics | 1.0 | $6.0M | 49k | 122.26 | |
Apple Computer | 1.0 | $5.8M | 53k | 110.37 | |
Auspex Pharmaceuticals | 1.0 | $5.8M | 110k | 52.48 | |
Ptc Therapeutics I (PTCT) | 1.0 | $5.7M | 110k | 51.77 | |
Mylan | 0.9 | $5.5M | 97k | 56.37 | |
Amgen | 0.9 | $5.5M | 120k | 45.40 | |
AMAG Pharmaceuticals | 0.9 | $5.3M | 125k | 42.62 | |
Vanda Pharmaceuticals (VNDA) | 0.9 | $5.3M | 368k | 14.32 | |
Medivation | 0.9 | $5.3M | 53k | 99.61 | |
Financial Select Sector SPDR (XLF) | 0.9 | $5.2M | 210k | 24.73 | |
Towers Watson & Co | 0.8 | $4.8M | 42k | 113.18 | |
TJX Companies (TJX) | 0.8 | $4.6M | 68k | 68.58 | |
Array BioPharma | 0.8 | $4.6M | 974k | 4.73 | |
Amicus Therapeutics (FOLD) | 0.8 | $4.6M | 550k | 8.32 | |
Clovis Oncology | 0.8 | $4.6M | 82k | 55.99 | |
Dyax | 0.8 | $4.5M | 318k | 14.06 | |
GlaxoSmithKline | 0.7 | $4.2M | 98k | 42.74 | |
Orbotech Ltd Com Stk | 0.7 | $4.2M | 281k | 14.80 | |
Forward Pharma A/s | 0.7 | $4.2M | 200k | 20.83 | |
Gilead Sciences Inc option | 0.7 | $4.0M | 394k | 10.03 | |
Cytokinetics (CYTK) | 0.7 | $4.0M | 493k | 8.01 | |
Relypsa | 0.7 | $3.9M | 127k | 30.80 | |
Broadcom Corporation | 0.7 | $3.8M | 89k | 43.33 | |
Puma Biotechnology (PBYI) | 0.7 | $3.8M | 20k | 189.25 | |
Cymabay Therapeutics | 0.7 | $3.8M | 390k | 9.83 | |
Ituran Location And Control (ITRN) | 0.6 | $3.7M | 168k | 22.08 | |
Receptos | 0.6 | $3.7M | 30k | 122.50 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 0.6 | $3.6M | 30k | 118.80 | |
CVS Caremark Corporation (CVS) | 0.6 | $3.5M | 37k | 96.31 | |
Teva Pharmaceutical Inds Ltd option | 0.6 | $3.5M | 464k | 7.52 | |
Applied Genetic Technol Corp C | 0.6 | $3.5M | 165k | 21.02 | |
Health Care SPDR (XLV) | 0.6 | $3.3M | 49k | 68.39 | |
Aegerion Pharmaceuticals | 0.6 | $3.4M | 160k | 20.94 | |
Trevena | 0.6 | $3.3M | 550k | 5.98 | |
Acorda Therapeutics | 0.6 | $3.2M | 79k | 40.87 | |
Catalyst Pharmaceutical Partners (CPRX) | 0.5 | $3.1M | 1.1M | 2.97 | |
Marinus Pharmaceuticals | 0.5 | $3.1M | 294k | 10.54 | |
Union Pacific Corporation (UNP) | 0.5 | $3.1M | 26k | 119.12 | |
Sangamo Biosciences (SGMO) | 0.5 | $3.0M | 200k | 15.21 | |
Arrowhead Resh | 0.5 | $3.0M | 400k | 7.38 | |
Macrogenics (MGNX) | 0.5 | $3.0M | 84k | 35.07 | |
Celladon | 0.5 | $2.9M | 151k | 19.53 | |
Sage Therapeutics (SAGE) | 0.5 | $2.9M | 80k | 36.60 | |
Snap-on Incorporated (SNA) | 0.5 | $2.9M | 21k | 136.75 | |
NPS Pharmaceuticals | 0.5 | $2.9M | 80k | 35.78 | |
Express Scripts Holding | 0.5 | $2.9M | 34k | 84.67 | |
Dicerna Pharmaceuticals | 0.5 | $2.9M | 177k | 16.47 | |
Alder Biopharmaceuticals | 0.5 | $2.9M | 100k | 29.09 | |
Keryx Biopharmaceuticals | 0.5 | $2.8M | 200k | 14.15 | |
Proqr Thrapeutics N V shs euro (PRQR) | 0.5 | $2.8M | 130k | 21.67 | |
Medicines Company | 0.5 | $2.8M | 100k | 27.67 | |
Ocera Therapeutics | 0.5 | $2.7M | 421k | 6.37 | |
Tekmira Pharmaceuticals Corporation | 0.5 | $2.7M | 175k | 15.15 | |
Aerie Pharmaceuticals | 0.4 | $2.6M | 89k | 29.19 | |
Sarepta Therapeutics (SRPT) | 0.4 | $2.5M | 175k | 14.47 | |
Uniqure Nv (QURE) | 0.4 | $2.5M | 168k | 14.81 | |
B Communications (BCOMF) | 0.4 | $2.4M | 134k | 18.02 | |
Cempra | 0.4 | $2.4M | 100k | 23.51 | |
Tokai Pharmaceuticals | 0.4 | $2.3M | 154k | 14.74 | |
Zafgen | 0.4 | $2.2M | 72k | 30.85 | |
CSX Corporation (CSX) | 0.4 | $2.2M | 60k | 36.23 | |
Ormat Technologies (ORA) | 0.4 | $2.1M | 309k | 6.90 | |
Enanta Pharmaceuticals (ENTA) | 0.3 | $2.0M | 40k | 50.85 | |
Vital Therapies | 0.3 | $2.0M | 82k | 24.93 | |
Nice Systems (NICE) | 0.3 | $2.0M | 40k | 50.64 | |
Ellomay Capital (ELLO) | 0.3 | $2.0M | 204k | 9.70 | |
Portola Pharmaceuticals | 0.3 | $2.0M | 70k | 28.31 | |
Concert Pharmaceuticals I equity | 0.3 | $2.0M | 150k | 13.32 | |
Starbucks Corporation (SBUX) | 0.3 | $2.0M | 24k | 82.04 | |
La Jolla Pharmaceuticl Com Par | 0.3 | $1.8M | 100k | 18.45 | |
Cti Biopharma | 0.3 | $1.8M | 750k | 2.36 | |
Intercept Pharmaceuticals In | 0.3 | $1.6M | 10k | 156.00 | |
Checkpoint Systems | 0.3 | $1.5M | 20k | 78.58 | |
Achillion Pharmaceuticals | 0.3 | $1.5M | 126k | 12.25 | |
VALEANT PHARMACEUTICALS Inte call | 0.2 | $1.4M | 97k | 14.35 | |
Amgen | 0.2 | $1.4M | 8.6k | 159.30 | |
Prothena (PRTA) | 0.2 | $1.3M | 63k | 20.76 | |
Wix (WIX) | 0.2 | $1.2M | 59k | 21.00 | |
Ignyta | 0.2 | $1.2M | 179k | 6.85 | |
Mannkind Corp Common Stock cmn | 0.2 | $1.2M | 300k | 3.85 | |
Genvec | 0.2 | $1.2M | 558k | 2.14 | |
Neurocrine Biosciences (NBIX) | 0.2 | $1.1M | 50k | 22.34 | |
Medgenics | 0.2 | $1.1M | 225k | 5.06 | |
Kamada Ord Ils1.00 (KMDA) | 0.2 | $1.1M | 294k | 3.71 | |
Eleven Biotherapeutics | 0.2 | $1.0M | 87k | 11.88 | |
Repros Therapeutics | 0.2 | $997k | 100k | 9.97 | |
Newlink Genetics Corporation | 0.2 | $994k | 25k | 39.76 | |
Zs Pharma | 0.1 | $860k | 21k | 41.58 | |
Oncothyreon | 0.1 | $813k | 428k | 1.90 | |
Palatin Technologies | 0.1 | $759k | 1.0M | 0.73 | |
Mast Therapeutics | 0.1 | $770k | 1.4M | 0.56 | |
Juno Therapeutics | 0.1 | $783k | 15k | 52.20 | |
Acelrx Pharmaceuticals | 0.1 | $673k | 100k | 6.73 | |
Ardelyx | 0.1 | $618k | 33k | 18.90 | |
Kalobios Pharmaceuticals | 0.1 | $605k | 350k | 1.73 | |
Mellanox Technologies | 0.1 | $535k | 13k | 42.74 | |
Israel Chemicals | 0.1 | $291k | 40k | 7.25 | |
Select Sector Spdr Tr option | 0.0 | $116k | 50k | 2.32 | |
Alcobra | 0.0 | $144k | 39k | 3.74 | |
Glaxosmithkline | 0.0 | $5.8k | 291k | 0.02 | |
Novavax | 0.0 | $9.0k | 1.5k | 5.83 |